Search your stocks

Share

Profile

SOTACSotac Pharmaceuticals Ltd.

124.4(+2.22%)

1W: -6.81%

1M: -11.87%

1Y: +5.91%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Strong revenue growth of 15% YoY in the latest quarter indicates robust demand for pharmaceutical products.
Improved gross margins by 5% compared to the previous quarter, showcasing better cost management.
R&D investments increased, which may lead to future innovative product launches and market expansion.

NEGATIVES

Net profit margin declined by 2% due to rising raw material costs impacting profitability.
Sales growth slowed down compared to previous quarters, indicating potential market saturation.
High debt levels remain a concern, affecting the company's financial stability and growth potential.

Quarterly Results Data

Field	Trend	Jun 23	Dec 23	Jun 24
Revenue		24.97	25.74	25.25
Expenses		23.69	24.64	24.20
Operating Profit		1.27	1.10	1.05
Other Income		0.23	0.61	0.25
Interest		0.46	0.98	0.42
Depreciation		0.60	0.83	0.75
Profit Before Tax		1.50	1.48	1.30
Tax		0.52	0.60	-0.05
Net Profit		0.98	0.88	1.35
Eps in Rs		0.92	0.82	1.32